Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Epitope Mapping of the Epstein-Barr Virus Latent Membrane Protein-2 in Ethnically Diverse Populations

NCT00070785 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT00070785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00070785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Epitope Mapping of the Epstein-Barr Virus Latent Membrane Protein-2 in Ethnically Diverse Populations
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Observational
Overall status
Completed
Start date
October 6, 2003
Completion date
April 21, 2008
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epstein-barr virus infections